Regencell Bioscience
4 hedge funds and large institutions have $9.27K invested in Regencell Bioscience in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, reducing their positions, and 0 closing their positions.
Holders
4
Holders Change
+2
Holders Change %
+100%
% of All Funds
0.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
TRCT
1
Tower Research Capital (TRC)
New York
|
$1.19K |
| 2 |
2
Morgan Stanley
New York
|
$4.56K |
| 3 |
3
Qube Research & Technologies (QRT)
London,
United Kingdom
|
$185 |
Top Sellers
No sellers this quarter
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Morgan Stanley
New York
| $4.56K | +$350 | +950 | +8% |
|
2
BlackRock
New York
| $3.33K | – | – | – |
|
|
TRCT
3
Tower Research Capital (TRC)
New York
| $1.19K | +$1.19K | +3,230 | New |
|
|
4
Qube Research & Technologies (QRT)
London,
United Kingdom
| $185 | +$185 | +494 | New |
|